Literature DB >> 15837789

NMR analysis of synthetic human serum albumin alpha-helix 28 identifies structural distortion upon amadori modification.

Mark J Howard1, C Mark Smales.   

Abstract

The non-enzymatic reaction between reducing sugars and long-lived proteins in vivo results in the formation of glycation and advanced glycation end products, which alter the properties of proteins including charge, helicity, and their tendency to aggregate. Such protein modifications are linked with various pathologies associated with the general aging process such as Alzheimer disease and the long-term complications of diabetes. Although it has been suggested that glycation and advanced glycation end products altered protein structure and helicity, little structural data and information currently exist on whether or not glycation does indeed influence or change local protein secondary structure. We have addressed this problem using a model helical peptide system containing a di-lysine motif derived from human serum albumin. We have shown that, in the presence of 50 mm glucose and at 37 degrees C, one of the lysine residues in the di-lysine motif within this peptide is preferentially glycated. Using NMR analysis, we have confirmed that the synthetic peptide constituting this helix does indeed form a alpha-helix in solution in the presence of 30% trifluoroethanol. Glycation of the model peptide resulted in the distortion of the alpha-helix, forcing the region of the helix around the site of glycation to adopt a 3(10) helical structure. This is the first reported evidence that glycation can influence or change local protein secondary structure. The implications and biological significance of such structural changes on protein function are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837789     DOI: 10.1074/jbc.M501480200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.

Authors:  Alin Stirban; Thomas Gawlowski; Michael Roden
Journal:  Mol Metab       Date:  2013-12-07       Impact factor: 7.422

Review 2.  An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.

Authors:  Km Neelofar; Jamal Ahmad
Journal:  Glycoconj J       Date:  2017-08-15       Impact factor: 2.916

3.  In vitro galactation of human serum albumin: analysis of the protein's galactation sites by mass spectrometry.

Authors:  Leslie Frost; Muhammad Chaudhry; Tiffany Bell; Menashi Cohenford
Journal:  Anal Biochem       Date:  2010-11-26       Impact factor: 3.365

4.  Structural mechanism of ring-opening reaction of glucose by human serum albumin.

Authors:  Yu Wang; Haiyang Yu; Xiaoli Shi; Zhipu Luo; Donghai Lin; Mingdong Huang
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

5.  Trifluoroethanol reveals helical propensity at analogous positions in cytoplasmic domains of three connexins.

Authors:  Alfredo G Fort; David C Spray
Journal:  Biopolymers       Date:  2009       Impact factor: 2.505

Review 6.  Review: Glycation of human serum albumin.

Authors:  Jeanethe Anguizola; Ryan Matsuda; Omar S Barnaby; K S Hoy; Chunling Wa; Erin DeBolt; Michelle Koke; David S Hage
Journal:  Clin Chim Acta       Date:  2013-07-24       Impact factor: 3.786

7.  Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Chunling Wa; Ronald L Cerny; William A Clarke; David S Hage
Journal:  Clin Chim Acta       Date:  2007-06-23       Impact factor: 3.786

8.  Role of advanced glycation end products in cardiovascular disease.

Authors:  Zeinab Hegab; Stephen Gibbons; Ludwig Neyses; Mamas A Mamas
Journal:  World J Cardiol       Date:  2012-04-26

9.  Nonenzymatic glycation interferes with fibronectin-integrin interactions in vascular smooth muscle cells.

Authors:  Srijita Dhar; Zhe Sun; Gerald A Meininger; Michael A Hill
Journal:  Microcirculation       Date:  2017-04       Impact factor: 2.628

Review 10.  Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.

Authors:  Margo P Cohen; Fuad N Ziyadeh; Sheldon Chen
Journal:  J Lab Clin Med       Date:  2006-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.